Abstract
For the NIH Long COVID Computational Challenge (L3C) in the Fall of 2022, we developed a machine learning model to predict who is at high risk for developing Long COVID, optimized for clinical deployment. Our submission won second prize in the competition. We present lessons learned, with details on the features, model selection and performance, fairness analysis, limitations, and deployment implications.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding. The study received an award from the NIH/N3C for a second place prize in the L3C.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Geisinger waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data used in the present study were made available through the NIH National COVID Cohort Collaborative (N3C) as a part of the Long COVID Computational Challenge (L3C)
